Evidence map›Paper›PMID 23344022›Full record

ReviewInternational journal of molecular sciences2012

Spatial regulation of epidermal growth factor receptor signaling by endocytosis.

Brian P Ceresa

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Revisiting Netrin-1: One Who Guides (Axons).Frontiers in cellular neuroscience · 2018
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis.Investigative ophthalmology & visual science · 2014
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Brian P CeresaDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA. brian.ceresa@louisville.edu.

Funding

Modulation of EGFR Signaling to Promote Corneal Epithelial Wound HealingR01EY021497 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CERESA, BRIAN P. · 2012 to 2014
$1.0M
Regulation of EGFR Signaling by the Endocytic PathwayR01GM092874 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CERESA, BRIAN P. · 2010 to 2013
$883k
NEI NIH HHS R01 EY021497NEI NIH HHS R01EY021497NIGMS NIH HHS R01 GM092874NIGMS NIH HHS R01GM092874
6 · The paper itself

Abstract

Signaling by cell surface receptors appears to be relatively straight-forward: ligand binds to the extracellular domain of the receptor and biochemical changes are communicated into the cell. However, this process is more complex than it first seems due to the various mechanisms that regulate signaling. In order to effectively target these receptors for pharmacological purposes, a more complete understanding of how their signaling is regulated is needed. Here, how the endocytic pathway regulates receptor signaling is discussed, using the epidermal growth factor receptor (EGFR) as a model. In particular, the spatial regulation of signaling is examined. Areas of discussion include: how endocytic trafficking affects biology/pathology, varying approaches for studying the relationship between receptor endocytosis and signaling, and developments in how the endocytic pathway controls EGFR:effector communication and EGFR-mediated cell biology.

Indexed as

EndocytosisSignal TransductionAnimalsErbB ReceptorsHumansModels, BiologicalErbB Receptors

Identifiers

PMID23344022
PMCPMC3565252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.